Hoeffe Julia, Vogel Regina G, Ammann Roland A
Department of Pediatric Emergency Medicine, Department of Pediatrics (JH), Inselspital, Bern University Hospital, University of Bern, Switzerland.
University of Bern (RGV), Bern, Switzerland.
J Pediatr Pharmacol Ther. 2022;27(5):436-442. doi: 10.5863/1551-6776-27.5.436. Epub 2022 Jul 6.
Combining intranasal fentanyl (IN FENT) with inhaled nitrous oxide (NO) seems to have good properties for pediatric procedural sedation and analgesia (PSA). This study aims to assess the side effect rate of the combined use of IN FENT and NO.
We performed a retrospective, single-center study. Patients treated in either the pediatric emergency department (PED) or the pediatric surgery outpatient clinic (PSOC) were included, if they received PSA with IN FENT and nitrous oxide with 50% oxygen (NO 50%).
Three hundred seventy-five patients were included over a period of 4 years. Median age was 9.4 years (range, 3.1 to 15.9) and 39% of patients were female. Overall side effect rate was 30% (114 patients). Most frequent was dizziness (n = 63, 17%; 95% CI, 13-21), followed by nausea (n = 23, 6%; 95% CI, 4-9) and emesis (n = 14, 4%; 95% CI, 2-6), with 35 patients having either nausea and/or emesis (9%; 95% CI, 7-13). No serious side effects were recorded (0%; 95% CI, 0-0.1). Of 298 patients with information regarding satisfaction, 280 patients would like the same sedation for a similar procedure in the future (94%; 95% CI, 90-96). We found no relation between previously described risk factors and emesis and/or nausea.
NO 50% combined with IN FENT can be recommended as an effective and safe treatment in the PED and the PSOC. While the side effect rate, primarily dizziness, nausea and emesis was substantial, antiemetic prophylaxis is not indicated owing to the overall low incidence of nausea and emesis.
鼻内给予芬太尼(IN FENT)与吸入一氧化二氮(NO)联合使用似乎对小儿程序性镇静和镇痛(PSA)具有良好特性。本研究旨在评估IN FENT与NO联合使用的副作用发生率。
我们进行了一项回顾性单中心研究。纳入在小儿急诊科(PED)或小儿外科门诊(PSOC)接受治疗的患者,前提是他们接受了IN FENT联合50%氧气的一氧化二氮(NO 50%)进行PSA。
在4年期间纳入了375例患者。中位年龄为9.4岁(范围3.1至15.9岁),39%的患者为女性。总体副作用发生率为30%(114例患者)。最常见 的是头晕(n = 63,17%;95%CI,13 - 21),其次是恶心(n = 23,6%;95%CI,4 - 9)和呕吐(n = 14,4%;95%CI,2 - 6),35例患者出现恶心和/或呕吐(9%;95%CI,7 - 13)。未记录到严重副作用(0%;95%CI,0 - 0.1)。在298例有满意度信息的患者中,280例患者希望未来在类似操作中采用相同的镇静方式(94%;95%CI,90 - 96)。我们未发现先前描述的风险因素与呕吐和/或恶心之间存在关联。
NO 50%与IN FENT联合使用可推荐为PED和PSOC中的一种有效且安全的治疗方法。虽然副作用发生率,主要是头晕、恶心和呕吐较为可观,但由于恶心和呕吐的总体发生率较低,不建议进行预防性止吐治疗。